tradingkey.logo
tradingkey.logo
Search

agilon health inc

AGL
Add to Watchlist
99.190USD
+0.760+0.77%
Close 07-28 16:00ETQuotes delayed by 15 min
1.65BMarket Cap
LossP/E TTM

AGL Income Statement

You can find the annual or quarterly income statement of agilon health inc here for insights into the performance and operational efficiency of agilon health inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q3
FY2020Q2
FY2020Q1
Total revenue
-7.33%1.42B
3.09%1.57B
-1.08%1.44B
-5.92%1.39B
-4.46%1.53B
86.69%1.52B
27.63%1.45B
38.69%1.48B
52.17%1.60B
120.54%815.50M
63.61%1.14B
59.54%1.07B
61.35%1.05B
145.18%369.78M
51.51%694.86M
34.31%670.13M
58.18%653.45M
--150.82M
46.67%458.61M
69.95%498.96M
41.94%413.10M
--312.68M
--293.59M
--291.05M
Revenue
-7.33%1.42B
3.09%1.57B
-1.08%1.44B
-5.92%1.39B
-4.46%1.53B
86.69%1.52B
27.63%1.45B
38.69%1.48B
52.17%1.60B
120.54%815.50M
63.61%1.14B
59.54%1.07B
61.35%1.05B
145.18%369.78M
51.51%694.86M
34.31%670.13M
58.18%653.45M
--150.82M
46.67%458.61M
69.95%498.96M
41.94%413.10M
--312.68M
--293.59M
--291.05M
Cost of revenue
-9.39%1.28B
8.07%1.65B
-1.01%1.50B
5.26%1.45B
-2.82%1.41B
64.86%1.53B
47.25%1.51B
47.26%1.38B
60.98%1.45B
186.04%925.13M
65.18%1.03B
58.79%937.12M
58.10%900.53M
130.55%323.43M
48.70%621.74M
32.31%590.18M
56.57%569.58M
--140.29M
58.21%418.12M
99.42%446.06M
45.02%363.78M
--264.28M
--223.68M
--250.85M
Operating expenses
-8.90%1.42B
6.16%1.73B
-1.13%1.57B
-0.99%1.51B
-3.51%1.55B
66.85%1.63B
34.71%1.58B
38.98%1.53B
52.91%1.61B
130.06%975.11M
62.37%1.18B
58.87%1.10B
61.10%1.05B
139.48%423.85M
46.57%724.38M
-13.31%691.19M
53.85%654.19M
--176.98M
53.23%494.21M
170.42%797.32M
43.23%425.22M
--322.53M
--294.85M
--296.88M
Depreciation, depletion, and amortization
-1.64%6.79M
7.69%7.00M
19.49%7.43M
23.90%7.32M
18.07%6.90M
170.83%6.50M
17.10%6.22M
7.11%5.91M
97.83%5.84M
100.00%2.40M
53.91%5.31M
81.30%5.51M
-12.42%2.95M
--1.20M
-12.37%3.45M
-15.83%3.04M
-1.58%3.37M
----
12.45%3.94M
3.79%3.61M
1.90%3.43M
--3.50M
--3.48M
--3.36M
Other operating expenses
----
---31.00K
----
----
---24.00K
----
----
----
----
33.84%-1.40M
---25.00K
---21.00K
----
-382.00%-2.12M
----
----
----
---439.00K
----
----
----
----
----
----
Operating profit
118.08%4.00M
-50.94%-157.74M
1.67%-131.27M
-167.69%-116.03M
-208.02%-22.11M
34.52%-104.50M
-239.77%-133.51M
-49.68%-43.34M
-1821.34%-7.18M
-195.20%-159.60M
-33.12%-39.29M
-37.55%-28.96M
156.12%417.00K
-106.65%-54.06M
17.09%-29.52M
92.94%-21.05M
93.87%-743.00K
---26.16M
-261.65%-35.60M
-23730.91%-298.36M
-107.66%-12.12M
---9.84M
---1.25M
---5.83M
Net non-operating interest income (expenses)
Non-operating interest expense
19.54%1.81M
9.02%1.72M
13.32%1.84M
-7.37%1.57M
17.99%1.52M
-16.54%1.57M
0.31%1.62M
9.13%1.70M
-14.00%1.28M
13.07%1.89M
61.70%1.62M
64.55%1.56M
71.41%1.49M
98.57%1.67M
15.34%1.00M
-36.92%945.00K
-70.38%871.00K
--840.00K
-55.61%867.00K
-27.98%1.50M
36.85%2.94M
--1.95M
--2.08M
--2.15M
Return on equity
-7.41%11.73M
-1126.87%-33.05M
541.57%13.13M
-45.64%5.41M
122.94%12.67M
66.40%-2.69M
-86.04%2.05M
17.50%9.96M
313.08%5.68M
-174.79%-8.02M
--14.66M
--8.47M
--1.38M
258.44%10.72M
----
----
----
---6.77M
----
----
----
----
----
----
Special income (expenses)
-1064.57%-6.11M
-988.86%-37.42M
-181.62%-4.09M
86.29%-119.00K
78.26%-525.00K
---3.44M
---1.45M
---868.00K
-1184.57%-2.42M
--0.00
100.00%0.00
100.00%0.00
88.95%-188.00K
100.00%0.00
40.19%-512.00K
-48.57%-5.71M
-105.31%-1.70M
---6.83M
32.97%-856.00K
-26.43%-3.85M
-149.70%-829.00K
---1.28M
---3.04M
---332.00K
Other non-operating income (expenses)
126.23%22.14M
462.29%42.37M
-22.73%13.53M
40.09%8.00M
17.80%9.79M
10.19%7.54M
222.96%17.51M
-19.44%5.71M
2.81%8.31M
67.21%6.84M
399.36%5.42M
-2.29%7.09M
103.48%8.08M
-17.76%4.09M
85.01%1.09M
6.46%7.25M
83.42%3.97M
--4.97M
-27.35%587.00K
129.55%6.81M
376.87%2.17M
--808.00K
--2.97M
--454.00K
Income before tax
1869.74%29.94M
-79.18%-187.56M
5.54%-110.54M
-244.88%-104.31M
-154.34%-1.69M
35.65%-104.67M
-461.82%-117.02M
-102.27%-30.25M
-61.99%3.11M
-297.50%-162.67M
30.44%-20.83M
26.91%-14.95M
1150.69%8.19M
-14.87%-40.92M
18.49%-29.94M
93.11%-20.46M
104.77%655.00K
---35.63M
-199.50%-36.74M
-8616.79%-296.89M
-74.53%-13.72M
---12.27M
---3.41M
---7.86M
Income tax
-85.71%28.00K
-24.64%1.32M
43.90%-331.00K
-85.13%62.00K
247.37%196.00K
558.05%1.76M
-148.76%-590.00K
-61.14%417.00K
92.44%-133.00K
-53.32%267.00K
116.46%1.21M
85.00%1.07M
-2377.46%-1.76M
219.55%572.00K
118.36%559.00K
33.33%580.00K
-543.75%-71.00K
--179.00K
631.43%256.00K
1015.38%435.00K
--16.00K
--35.00K
--39.00K
--0.00
Income after tax
1684.53%29.92M
-77.47%-188.88M
5.35%-110.21M
-240.39%-104.37M
-158.15%-1.89M
34.68%-106.43M
-428.30%-116.43M
-91.33%-30.66M
-67.37%3.25M
-292.66%-162.93M
27.75%-22.04M
23.82%-16.03M
1270.66%9.95M
-15.89%-41.49M
17.54%-30.50M
92.92%-21.04M
105.29%726.00K
---35.80M
-200.73%-36.99M
-8530.74%-297.33M
-74.74%-13.74M
---12.30M
---3.44M
---7.86M
Net income from continuous operations
1684.53%29.92M
-77.47%-188.88M
5.35%-110.21M
-240.39%-104.37M
-158.15%-1.89M
34.68%-106.43M
-428.30%-116.43M
-91.33%-30.66M
-67.37%3.25M
-292.66%-162.93M
27.75%-22.04M
23.82%-16.03M
1270.66%9.95M
-15.89%-41.49M
17.54%-30.50M
92.92%-21.04M
105.29%726.00K
---35.80M
-200.73%-36.99M
-8530.74%-297.33M
-74.74%-13.74M
---12.30M
---3.44M
---7.86M
Net income from discontinued operations
35.71%19.00M
-100.00%0.00
100.00%0.00
--0.00
250.85%14.00M
100.95%640.00K
87.47%-1.18M
100.00%0.00
-254.48%-9.28M
-348.72%-67.55M
-3901.69%-9.44M
-350.49%-769.00K
1300.47%6.01M
28.08%-15.05M
-122.80%-236.00K
119.04%307.00K
130.32%429.00K
---20.93M
118.35%1.03M
63.91%-1.61M
82.82%-1.42M
--474.00K
---4.47M
---8.24M
Net Income attributable to non-controlling interests
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
100.00%0.00
100.00%0.00
143.48%20.00K
147.62%30.00K
38.55%-51.00K
33.80%-47.00K
43.90%-46.00K
16.00%-63.00K
-418.75%-83.00K
38.26%-71.00K
14.58%-82.00K
-2.74%-75.00K
---16.00K
---115.00K
---96.00K
---73.00K
--0.00
----
----
Net income attributable to controlling interests
303.86%48.92M
-78.54%-188.88M
6.30%-110.21M
-240.17%-104.37M
299.74%12.11M
54.09%-105.79M
-274.14%-117.61M
-83.19%-30.68M
-137.85%-6.06M
-308.09%-230.43M
-2.50%-31.44M
18.89%-16.75M
1202.60%16.02M
0.45%-56.47M
14.44%-30.67M
93.09%-20.65M
108.16%1.23M
---56.72M
-203.06%-35.84M
-3677.59%-298.85M
6.34%-15.08M
---11.83M
---7.91M
---16.10M
Net income attributable to common shareholders
303.86%48.92M
-78.54%-188.88M
6.30%-110.21M
-240.17%-104.37M
299.74%12.11M
54.09%-105.79M
-274.14%-117.61M
-83.19%-30.68M
-137.85%-6.06M
-308.09%-230.43M
-2.50%-31.44M
18.89%-16.75M
1202.60%16.02M
0.45%-56.47M
14.44%-30.67M
93.09%-20.65M
108.16%1.23M
---56.72M
-203.06%-35.84M
-3677.59%-298.85M
6.34%-15.08M
---11.83M
---7.91M
---16.10M
Basic earnings per share
9947.46%2.95
-4335.91%-11.39
6.95%-0.27
-238.07%-0.25
297.77%0.03
55.50%-0.26
-268.87%-0.29
-82.75%-0.07
-138.24%-0.01
-321.09%-0.58
-3.83%-0.08
19.47%-0.04
1167.32%0.04
4.19%-0.14
18.57%-0.07
93.60%-0.05
107.79%0.00
---0.14
-197.47%-0.09
-3743.50%-0.79
6.35%-0.04
---0.03
---0.02
---0.04
Diluted earnings per share
9909.48%2.94
-4335.91%-11.39
6.95%-0.27
-238.07%-0.25
297.77%0.03
55.50%-0.26
-268.87%-0.29
-82.75%-0.07
-139.48%-0.01
-321.09%-0.58
-3.83%-0.08
19.47%-0.04
1195.17%0.04
4.19%-0.14
18.57%-0.07
93.60%-0.05
107.39%0.00
---0.14
-197.47%-0.09
-3743.50%-0.79
6.35%-0.04
---0.03
---0.02
---0.04
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read agilon health inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing AGL stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was agilon health inc's revenue at year end?

agilon health inc reported 5.93B in revenue for fiscal year 2025, up from 6.06B in the previous year.

How much revenue did agilon health inc report in the most recent quarter?

agilon health inc reported 1.42B in revenue for the most recent quarter, an increase of -7.33% year over year.

What was agilon health inc's net income for the year?

agilon health inc posted -391.35M in net income for fiscal year 2025.

How much net income did agilon health inc post in the last quarter?

agilon health inc reported 48.92M in net income for the latest quarter。

What was agilon health inc's annual operating profit?

agilon health inc's operating income was -427.15M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.